about
CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccineThe proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.Resistance to Toxoplasma gondii infection in mice treated with silk protein by enhanced immune responsesEnhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge.CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine.Preliminary evaluation of the immunoenhancement potential of Newcastle disease vaccine formulated as a cationic liposome.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Innate immunity and biodefence vaccines.
@ast
Innate immunity and biodefence vaccines.
@en
type
label
Innate immunity and biodefence vaccines.
@ast
Innate immunity and biodefence vaccines.
@en
prefLabel
Innate immunity and biodefence vaccines.
@ast
Innate immunity and biodefence vaccines.
@en
P2093
P1476
Innate immunity and biodefence vaccines.
@en
P2093
Derek T O'Hagan
Jeffrey B Ulmer
Nicholas M Valiante
P304
P356
10.1046/J.1462-5822.2003.00318.X
P577
2003-11-01T00:00:00Z